Christoph KALIS,Bruno BIETH,Christoph BURKHART,Andreas CHRIST,Stefan DE BUCK,Sam LINDGREN
申请号:
MX2018009758
公开号:
MX2018009758A
申请日:
2017.02.10
申请国别(地区):
MX
年份:
2018
代理人:
摘要:
The invention relates to the use of 1-{(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)- 5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-ylamino]-pyrrolidin -1-yl}-propan-1-one or pharmaceutically acceptable salts thereof for the treatment of primary Sjögren's Syndrome.La invención se refiere al uso de 1-{(S)-3-[6-(6-metoxi-5-trifluor ometil-piridin-3-il)-5,6,7,8-tetrahidro-pirido[4,3-d]pirimidin-4- ilamino]-pirrolidin-1-il}-propan-1-ona o sales farmacéuticamente del mismo para el tratamiento de síndrome de Sjögren primario.